IAMI partners with BioNovus to develop bladder cancer drug
IAMI and BioNovus join to speed biotech, pharma commercialization on bladder cancer drug. Read More
Project Aims to Introduce New Cancer Drugs to Market
Researchers at the University of Kansas Medical Center are hoping that a new project can bring two new cancer drugs to market - one for humans and another for their furry friends. Read More
Higuchi Biosciences Center announces the 2016 J.R. and Inez Jay Fund research awards
Three projects were selected this year to receive the 2016 J.R. and Inez Jay Fund research award. Learn more
Institute for Advancing Medical Innovation
The Institute for Advancing Medical Innovation (IAMI) serves as a national model for philanthropy, industry and universities to collaborate in advancing university innovations in life sciences by:
Vision Change the standard of care for pediatric, adolescent and adult patients living with diseases including cancer and rare diseases.
Mission Discover and develop pharmaceuticals and diagnostics with a clear path to market.
Core Hypothesis The investment in high potential academic projects with industry-experienced leadership will enhance the yield of commercial products that benefit patients.
Children's Mercy Kansas City
Together, IAMI and Children's Mercy Kansas City have advanced several discoveries to patient treatments.
Frontiers Heartland Institute
IAMI and Frontiers accelerate the process of lab discoveries becoming patient treatments.
KU Cancer Center
Innovation and discovery drive the partnership between The University of Kansas Cancer Center and IAMI.
KU Endowment financially supports IAMI to bring new drugs and treatments to the market.
Feb 16, 2016